Dr. Bruce Ryan Ball, M.D. Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-539-9582 |
Dr. Jerome Lloyd Buller, M.D. Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-539-2720 |
Dr. Amy Nichole Brown, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-5337 |
Dr. Samantha Simpson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-539-9582 |
Dr. Stuart Solomon Winkler, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-3170 |
Shenika Pritam Shah, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-220-7883 |
News Archive
Funded by the European Union, MoniQA (Monitoring and Quality Assurance in the total food supply chain) involves experts from around the globe collaborating to harmonise worldwide food quality and safety monitoring and control strategies. The project has developed a database of food quality and safety issues and corresponding analytical tools for food production and the supply chain.
The list of known genetic mitochondrial disorders is ever-growing, and ongoing research continues to identify new disorders in this category.
John Walker, M.D., C.P.E., Chief Medical Officer, Cornerstone Health Care, is presenting Cornerstone's successful use of Humedica MinedShareTM Ambulatory as a basis for its new Patient Care Advocate program.
In the life of almost every household appliance, there comes that moment of out with the old and in with the new. However, while electrical and electronic equipment have never been more efficient, economical or in demand, consumers' desire to own the best and the latest is contributing to an environmental issue of increasing seriousness and concern.
Keraderm Corp. announced the closing today of a $2.5 million dollar Series A investment by NewVa Capital Partners, LP. Currently starting clinical trials, the company's platform harnesses phototherapy technology to treat nail and skin infections. NewVa Capital Partners is a private equity and venture capital fund managed by Third Security, LLC and provides early stage investments in companies located or considering location in the NewVa region of southwest Virginia. This is Keraderm's first institutional investment round.
› Verified 4 days ago